A. Malik
Equibles does not estimate personal net worth.
Get an email with a short summary when Pfizer Inc publishes a filing, an earnings call transcript or a press release.
Get PFE alertsAbout A. Malik
The proxy statement of Pfizer Inc reports total compensation of $9,429,227 for A. Malik in fiscal 2025, including a base salary of $1,386,817. Disclosed compensation is on record for 3 fiscal years. Pfizer Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Pfizer Inc includes A. Bourla (CEO), I. Read (Chairman), Cecile Guegan (CFO) and 7 others.
Affiliation history
-
Pfizer Inc (PFE)
Proxy statement
Current
Company network
Leadership on record at Pfizer Inc
- A. Bourla CEO
- I. Read Chairman
- Cecile Guegan CFO
- D. Denton CFO
- David M. Denton CFO
- F. D’Amelio CFO
- Jennifer B. Damico Chief Accounting Officer
- James Quincey Board Member
- Susan Desmond-Hellmann Board Member
- Susan Hockfield Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Pfizer Inc (PFE) | Chief U.S. Commercial Officer, EVP | $1,386,817 | $9,429,227 |
| 2024 | Pfizer Inc (PFE) | Chief U.S. Commercial Officer, EVP | $1,344,825 | $8,294,270 |
| 2023 | Pfizer Inc (PFE) | Chief U.S. Commercial Officer, EVP | $1,294,800 | $5,420,734 |
Recent activity
No call appearances or filed executive changes recorded yet.